Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,481,899
  • Shares Outstanding, K 49,862
  • Annual Sales, $ 1,793 M
  • Annual Income, $ 230,900 K
  • 60-Month Beta 0.98
  • Price/Sales 0.85
  • Price/Cash Flow 3.62
  • Price/Book 1.01
Trade EBS with:

Options Overview Details

View History
  • Implied Volatility 61.15% ( -9.45%)
  • Historical Volatility 63.19%
  • IV Percentile 50%
  • IV Rank 26.21%
  • IV High 119.53% on 05/20/22
  • IV Low 40.41% on 09/17/21
  • Put/Call Vol Ratio 0.03
  • Today's Volume 31
  • Volume Avg (30-Day) 365
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 6,708
  • Open Int (30-Day) 4,446

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.02
  • Low Estimate -0.15
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.13 +11.28%
on 08/02/22
36.14 -16.46%
on 07/28/22
-3.50 (-10.39%)
since 07/08/22
3-Month
26.85 +12.44%
on 06/16/22
40.45 -25.36%
on 05/23/22
-0.21 (-0.69%)
since 05/10/22
52-Week
26.85 +12.44%
on 06/16/22
65.09 -53.62%
on 08/30/21
-30.17 (-49.98%)
since 08/10/21

Most Recent Stories

More News
Emergent BioSolutions to Participate in Investor Conferences

GAITHERSBURG, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive...

EBS : 30.55 (+2.79%)
Why Emergent BioSolutions Stock Is Sinking Today

The company reported disappointing Q2 results.

EBS : 30.55 (+2.79%)
Emergent's (EBS) Q2 Earnings and Revenues Miss Estimates

Emergent's (EBS) second-quarter 2022 earnings and revenues miss estimates. EBS issues fresh guidance for its CDMO services.

AZN : 65.95 (+0.09%)
NVS : 86.91 (-0.28%)
JNJ : 169.62 (-0.33%)
EBS : 30.55 (+2.79%)
Emergent BioSolutions (EBS) Q2 2022 Earnings Call Transcript

EBS earnings call for the period ending June 30, 2022.

EBS : 30.55 (+2.79%)
Emergent Biosolutions (EBS) Reports Q2 Loss, Misses Revenue Estimates

Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -236.51% and 16.64%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

EBS : 30.55 (+2.79%)
VIR : 30.37 (+5.31%)
Emergent BioSolutions Reports Financial Results for Second Quarter 2022

Reports strong core products segment performance offset by impact of continuing post-COVID transition and re-baselining of CDMO services segmentResumes...

EBS : 30.55 (+2.79%)
Why Emergent BioSolutions Stock Is Jumping This Week

Worries about the monkeypox outbreak have driven Emergent's shares higher.

EBS : 30.55 (+2.79%)
CMRX : 2.48 (+1.64%)
Emergent BioSolutions to Release Second Quarter 2022 Financial Results and Conduct Conference Call on August 1, 2022

GAITHERSBURG, Md., July 18, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, August 1, 2022, at...

EBS : 30.55 (+2.79%)
Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola

GAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an...

EBS : 30.55 (+2.79%)
Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors

GAITHERSBURG, Md., July 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s board of directors...

EBS : 30.55 (+2.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside...

See More

Key Turning Points

3rd Resistance Point 31.80
2nd Resistance Point 31.24
1st Resistance Point 30.48
Last Price 30.55
1st Support Level 29.16
2nd Support Level 28.60
3rd Support Level 27.84

See More

52-Week High 65.09
Fibonacci 61.8% 50.48
Fibonacci 50% 45.97
Fibonacci 38.2% 41.46
Last Price 30.55
52-Week Low 26.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar